Apyx Medical CorporationAPYXNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-18.77M
↓ 46% below average
Average (9y)
$-12.85M
Historical baseline
Range
High:$-3.12M
Low:$-21.37M
CAGR
+13.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-18.77M | -224.6% |
| 2023 | $-5.78M | +72.8% |
| 2022 | $-21.29M | -90.6% |
| 2021 | $-11.17M | +32.9% |
| 2020 | $-16.65M | +15.8% |
| 2019 | $-19.78M | +7.5% |
| 2018 | $-21.37M | -393.9% |
| 2017 | $-4.33M | -38.6% |
| 2016 | $-3.12M | +49.7% |
| 2015 | $-6.21M | - |